HIGHLIGHTS
- who: Xiaoxia Tian from the University of Florence, Italy have published the paper: The antihyperlipidemic drug potassium piperonate impairs the migration and tumorigenesis of breast cancer cells via the upregulation of miR-31, in the Journal: (JOURNAL)
- what: The authors investigated the mechanisms underlying the GBK-mediated impairment of breast cancer cell invasion and metastasis at the cellular and molecular levels. The authors propose a possible signaling network whereby GBK acts by inhibiting the migration and invasion of breast cancer cells . The authors have shown that GBK affects the expression of RHOA, SATB2, and WAVE3 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.